By Year : Latest | All | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011
- 09 December 2024 Clarification on the Significant Amend of the Financial Statements for the year 2023 and Q.3.24 (Restated) (Revised Subject and Template)
- 09 December 2024 Report of the Public Presentation
- 09 December 2024 The company has resolved its financial condition or operation as ordered by the regulator.
- 04 December 2024 Financial Performance Yearly (F45) (Audited) (Revised)
- 04 December 2024 Management Discussion and Analysis Quarter 3 Ending 30 Sep 2024 (Revised)
- 04 December 2024 Financial Performance Quarter 3 (F45) (Reviewed) (Revised)
- 04 December 2024 Management Discussion and Analysis Yearly Ending 31 Dec 2023 (Revised)
- 04 December 2024 Financial Performance Yearly (F45) (Audited) (Revised)
- 04 December 2024 Financial Statement Quarter 3/2024 (Reviewed) (Revised)
- 04 December 2024 Financial Statement Yearly 2023 (Audited) (Revised)
- 28 November 2024 Notification convening date of the Public Presentation
- 21 November 2024 Clarification regarding SEC's instruction for the Company to amend the Financial Statements for FY 2023 and Q3 2024
- 20 November 2024 SEC instructs NUSA to amend financial statements for the year 2023 and Q3 of 2024
- 20 November 2024 Informing the Company's Board of Directors Meeting No. 10/2567 resolution regarding the change of stock ticker and the amendment of the PPO Record Date and subscription period. (Revised PDF)
- 20 November 2024 Informing the Company's Board of Directors Meeting No. 10/2567 resolution regarding the change of stock ticker and the amendment of the PPO Record Date and subscription period. (Revised)
- 20 November 2024 Informing the Company's Board of Directors Meeting No. 10/2567 resolution regarding the change of stock ticker and the amendment of the PPO Record Date and subscription period. (Revised)
- 20 November 2024 SP, CS signs posted on NUSA's securities as the SEC has notified NUSA to rectify the financial statements of the year 2023 and Q3/2024
- 19 November 2024 Informing the Company's Board of Directors Meeting No. 10/2567 resolution regarding the change of stock ticker and the amendment of the PPO Record Date and subscription period. (Revised)
- 14 November 2024 Informing the Company's Board of Directors Meeting No. 9/2567 resolution regarding the capital increase through a PPO, convertible securities (NUSA-W6) issuance, and the Company's name change. (Revised)
- 14 November 2024 Resolution of the Company's Board of Directors No. 9/2024 (Revised)